Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 10, 2026 07:00 ET | Source: Aclarion, Inc.

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
June 09, 2026 07:00 ET | Source: Aclarion, Inc.

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
June 08, 2026 07:05 ET | Source: Aclarion, Inc.

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal
June 08, 2026 07:00 ET | Source: Aclarion, Inc.

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting
June 01, 2026 06:00 ET | Source: Aclarion, Inc.

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune Biomarker Study
May 28, 2026 14:49 ET | Source: Aclarion, Inc.

Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

Aclarion Comments on Echo Lake Capital’s Letter and Unsolicited Proposal
May 07, 2026 06:00 ET | Source: Aclarion, Inc.

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment
May 06, 2026 06:00 ET | Source: Aclarion, Inc.

Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.

Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.
April 30, 2026 06:00 ET | Source: Aclarion, Inc.

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption
April 28, 2026 06:00 ET | Source: Aclarion, Inc.

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan